186 related articles for article (PubMed ID: 6682144)
1. Morphine-induced supersensitivity to the effects of naloxone on luteinizing hormone secretion in the male rat.
Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
J Pharmacol Exp Ther; 1983 Apr; 225(1):35-41. PubMed ID: 6682144
[TBL] [Abstract][Full Text] [Related]
2. Opiate withdrawal-induced hyposensitivity to naloxone's effects on serum luteinizing hormone in the male rat.
Cicero TJ; Aleem A; Meyer ER; Schmoeker PF; Miller BT
J Pharmacol Exp Ther; 1986 Sep; 238(3):1063-70. PubMed ID: 3528453
[TBL] [Abstract][Full Text] [Related]
3. Opiate-induced enhancement of the effects of naloxone on serum luteinizing hormone levels in the male rat: specificity for Mu agonists.
Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
J Pharmacol Exp Ther; 1983 Sep; 226(3):770-5. PubMed ID: 6310081
[TBL] [Abstract][Full Text] [Related]
4. Development of tolerance to the effects of morphine on luteinizing hormone secretion as a function of castration in the male rat.
Cicero TJ; Meyer ER; Schmoeker PF
J Pharmacol Exp Ther; 1982 Dec; 223(3):784-9. PubMed ID: 7143239
[TBL] [Abstract][Full Text] [Related]
5. Development of acute tolerance to the effects of naloxone on the hypothalamic-pituitary-luteinizing hormone axis in the male rat.
Owens DP; Cicero TJ
J Pharmacol Exp Ther; 1981 Jan; 216(1):135-41. PubMed ID: 7005427
[TBL] [Abstract][Full Text] [Related]
6. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
Windh RT; Little PJ; Kuhn CM
J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
[TBL] [Abstract][Full Text] [Related]
7. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats.
Cicero TJ; Nock B; O'Connor L
J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870
[TBL] [Abstract][Full Text] [Related]
8. Ontogeny of the opioid-mediated control of reproductive endocrinology in the male and female rat.
Cicero TJ; Schmoeker PF; Meyer ER; Miller BT; Bell RD; Cytron SM; Brown CC
J Pharmacol Exp Ther; 1986 Mar; 236(3):627-33. PubMed ID: 3512817
[TBL] [Abstract][Full Text] [Related]
9. Enhanced naloxone distribution to the brain by morphine pretreatment in mice.
Lange DG; Fujimoto JM; Roerig S; Wang RI
Drug Metab Dispos; 1977; 5(2):167-73. PubMed ID: 15809
[TBL] [Abstract][Full Text] [Related]
10. Age-related differences in the sensitivity to opiate-induced perturbations in reproductive endocrinology in the developing and adult male rat.
Cicero TJ; O'Connor L; Nock B; Adams ML; Miller BT; Bell RD; Meyer ER
J Pharmacol Exp Ther; 1989 Jan; 248(1):256-61. PubMed ID: 2643703
[TBL] [Abstract][Full Text] [Related]
11. Alterations in the antagonism by naloxone of morphine-induced respiratory depression and analgesia after morphine pretreatment.
McGilliard KL; Takemori AE
J Pharmacol Exp Ther; 1978 Dec; 207(3):884-91. PubMed ID: 731438
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic methadone administration on neuroendocrine function in young adult rats.
Kuhn CM; Bartolome MB
J Pharmacol Exp Ther; 1985 Jul; 234(1):204-10. PubMed ID: 4040169
[TBL] [Abstract][Full Text] [Related]
13. Age-related differences in the sensitivity of serum luteinizing hormone to prototypic mu, kappa and delta opiate agonists and antagonists.
Cicero TJ; Meyer ER; Miller BT; Bell RD
J Pharmacol Exp Ther; 1988 Jul; 246(1):14-20. PubMed ID: 2839658
[TBL] [Abstract][Full Text] [Related]
14. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
Neal BS; Sparber SB
J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
[TBL] [Abstract][Full Text] [Related]
15. Modification of the development of acute opiate tolerance by increased dopamine receptor sensitivity.
Martin JR; Takemori AE
J Pharmacol Exp Ther; 1987 Apr; 241(1):48-55. PubMed ID: 3572795
[TBL] [Abstract][Full Text] [Related]
16. Plasma malondialdehyde levels and opiate withdrawal signs observed in rats treated with morphine plus naloxone: effects of alpha-lipoic acid administration.
Pinelli A; Cighetti G; Trivulzio S
Fundam Clin Pharmacol; 2008 Aug; 22(4):439-45. PubMed ID: 18705754
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of morphine dependence by naloxone in acutely dependent mice.
Sofuoglu M; Sato J; Takemori AE
J Pharmacol Exp Ther; 1990 Sep; 254(3):841-6. PubMed ID: 2395116
[TBL] [Abstract][Full Text] [Related]
18. Changes in sensitivity to apomorphine during morphine dependence and withdrawal in rats.
Cox B; Ary M; Lomax P
J Pharmacol Exp Ther; 1976 Mar; 196(3):637-41. PubMed ID: 944260
[TBL] [Abstract][Full Text] [Related]
19. Opioid-induced suppression of rat testicular function.
Adams ML; Sewing B; Forman JB; Meyer ER; Cicero TJ
J Pharmacol Exp Ther; 1993 Jul; 266(1):323-8. PubMed ID: 8392556
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of opiate-induced depressions in serum luteinizing hormone levels by the prior administration of naloxone in the male rat.
Cicero TJ; Owens DP; Schmoeker PF; Meyer ER
Life Sci; 1984 Sep; 35(12):1321-8. PubMed ID: 6090834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
